Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LX1033 in IBS-D
NCT01494233Phase 2Completed
- Sponsor
- Lexicon Pharmaceuticals, Inc.
- Start
- Feb 2012
- Primary completion
- Sep 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of telotristat ethyl in Irritable bowel syndrome with diarrhea (IBS-D), sponsored by Lexicon Pharmaceuticals, Inc.. Started Feb 2012; status: completed.
02
Drugs
telotristat ethyl
03
Conditions
Irritable bowel syndrome with diarrhea (IBS-D)
Beyond the preview
Go deeper on NCT01494233.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01494233.